|
|
| MRD / Regn No. |
: 20250000735 |
Date |
: 23/06/2026 |
| Patient Name |
: Mrigen Uzir |
Age & Gender |
: 63 Yrs. / Male |
| Contact No. |
: 9435340376 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (17/Sep/2008) | |
|
Subjective |
: |
TYPE 2 DM,HAS STOPPED OZEMPIC
|
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM,INCREASED FIB4 / NAFLD SCORE,S3F1 MASLD,MILD TSH ELEVATION,A1G2 DKD |
|
Plan |
: |
INCREASED SEMAGLUTIDE 1 MG,SEE ME IN 6 WEEKS |
|
| Salient Investigations |
: |
FASTING PLASMA GLUCOSE (FPG): 152 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 228 mg/dL |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET DAPAGLIFLOZIN 10 MG PIOGLITAZONE 15 MG
GLUXIT PRO
Medicine For DIABETES NAFLD |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GENTIOURINARY INFECTION AND EDEMA | |
|
2 |
INJECTION DEGLUDEC (INJ U100)
TRESIBA
Medicine For DIABETES |
SQ |
0-0-6 UNITS |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
3 |
INJECTION SEMAGLUTIDE 1 MG
OZEMPIC
Medicine For OBESITY DIABETES |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA VOMITING | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 07/Aug/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription |
Powered By:  |